Ageing and associations of fasting plasma glucose and 2h plasma glucose with HbA 1C in apparently healthy population. "FIN-D2D" study

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages 344-349

  Saltevo, J T ^a   Kautiainen, H ^a,h   Niskanen, L ^b   Oksa, H ^c   Puolijoki, H ^d   Sundvall, J ^e   Keinanen Kiukaanniemi S ^f   Peltonen, M ^e   Tuomilehto, J ^g   Uusitupa, M ^h   Mantyselka P ^h   Vanhala, M J ^a,h  

^a CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d South Ostrobothnia Hospital District   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF OULU   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

2h plasma glucose ageing; Fasting plasma glucose; HbA 1C; Oral glucose tolerance test

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GERIATRICS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; RECEIVER OPERATING CHARACTERISTIC; SEX RATIO;

AGE FACTORS; AGED; AGING; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 80052768208     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.05.006     Document Type: Article

References (32)

1. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation. Geneva, World Health Org.; 2006.
2. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
3. Sacks D.B. A1c versus glucose testing: a comparison. Rev Diabetes Care 2011, 34:518-523.
4. Sicree R.A., Zimmet P.Z., Dunstan D.W., Cameron A.J., Welborn T.A., Shaw J.E. Differences in height explain gender differences in the response to the oral glucose tolerance test: the AusDiab study. Diabet Med 2008, 25:296-302.
5. Williams J.W., Zimmet P.Z., Shaw J.E., de Courten M.P., Cameron A.J., Chitson P., et al. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter?. Diabet Med 2003, 20:915-920.
6. Rathmann W., Strassburger K., Giani G., Döring A., Meisinger C. Differences in height explain gender differences in the response to the oral glucose tolerance test. Diabet Med 2008, 25:1374-1375.
7. Faerch K., Borc-Johnsen K., Vaag A., Jørgensen A., Witte D.R. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 2010, 53:858-865.
8. Davidson M.B. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979, 28:688-705.
9. Pani L.N., Korenda L., Meigs J.B., Driver C., Chamany S., Fox C.S., et al. Effect of aging on A1c levels in individuals without diabetes. Evidence from the Framingham Offspring study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008, 31:1991-1996.
10. RaviKumar P., Bhansali A., Walia R., Shanmugasundar G., Ravikiran M. Alterations in HbA1c with advancing age in subjects with normal glucose tolerance: Chadigarh Urban Diabetes study group. Diabet Med 2011, 10.1111/j.1464-5491.2011.03242.x.
11. Nakashima K, Nishizaki O., Andoh Y. Accelaration of hemoglobin glycation with ageing. Clin Chim Acta 1993, 215:111-118.
12. Kilpatrick E.S., Dominiczak M.H., Small M. The effects of ageing on glycation and the interpretation of glycaemic control in type 2 diabetes. Q J Med 1996, 89:307-312.
13. WHO MONICA Project Principal Investigators The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988, 41(2):105-114.
14. Katz A., Nambi S.S., Mather K., Baron A.D., Follman D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
15. Study Group DECODE Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26(1):61-69.
16. Lipska K.J., De Rekeneire N., Van Ness P.H., Johnson K.C., Kanaya A., Koster A., et al. Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab 2010, 95:5289-5295.
17. Rathmann W., Kowall B., Tamayo T., Giani G., Holle R., Thorand B., et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations. The KORA S2/F4 study. Ann Med 2010, (November). [epub ahead of print]. 10.3109/07853890.2010.531759.
18. Olson D.E., Rhef M.K., Herrick K., Ziemer D.C., Twombly J.G., Phillips L.S. Screening for diabetes and prediabetes with proposed A1c-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
19. Jørgensen M.E., Bjerregaard P., Borch-Jensen K., Witte D. New diagnostic criteria for diabetes: Is the change from glucose to HbA1c possible in all populations?. J Clin Endocrinol Metab 2010, 95(11):E333-E336.
20. Cohen R.M., Snieder H., Lindsell C.J., Beyan H., Hawa M.I., Blinko S., et al. Evidence for independent heritability of the glycosylation gap fraction of HbA1c in non-diabetic twins. Diabetes Care 2006, 29:1739-1743.
21. Dagogo-Jack S. Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum. Nat Rev Endocrinol 2010, 6(10):589-593.
22. Ford E.S., Cowie C.C., Li C., Handelsman Y., Bloomgarden Z.T. Iron deficiency anemia, non-iron deficiency anemia and HbA1c among adults in the United States. J Diabetes 2010, (October). [epub ahead of print]. 10.1111/j.1753-0407.2010.00100.x.
23. Kramer C.K., Araneta M.R.G., Barrett-Connor E. A1c and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 2010, 33:101-103.
24. Pajunen P., Peltonen M., Eriksson J.G., Ilanne-Parikka P., Aunola S., Keinänen-Kiukaanniemi S., et al. For the Finnish Diabetes Prevention study (DPS). HbA1c in diagnosing and predicting type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention study. Diabet Med 2011, 28:36-42.
25. Cederberg H., Saukkonen T., Laakso M., Jokelainen J., Härkönen P., Timonen M., et al. Postchallenge glucose, A1c, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease. Diabetes Care 2010, 33:2077-2083.
26. Ning F., Tuomilehto J., Pyörälä K., Onat A., Söderberg S., Qiao Q. For the DECODE Study Group. Cardiovascular disease mortality in Europeans in relation to fasting and 2h plasma glucose levels within a normoglycemic range. Diabetes Care 2010, 33:2211-2216.
27. Selvin E., Steffes M.W., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in non-diabetic adults. N Engl J Med 2010, 362:800-811.
28. Skriver M.V., Borch-Johnsen K., Lauritzen T., Sandbaek A. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION), Denmark. Diabetologia 2010, 53:2328-2333.
29. Sarwar N., Aspelund T., Eiriksdottir G., Gobin R., Seshasai S.R., Forouhi N.G., et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med 2010, 7(5):e1000278.
30. Boronat M., Saavedra P., López-Ríos L., Riaño M., Wägner A.M., Nóvoa F.J. Differences in cardiovascular risk profile of diabetic subjects discordantly classified by diagnostic criteria based on glycated hemoglobin and oral glucose tolerance test. Diabetes Care 2010, 33:2671-2673.
31. Qiao Q., Dekker J.M., de Vegt F., Nijpels G., Nissinen A., Stehouwer C.D., et al. Two prospective studies found that elevated 2h glucose predicted male mortality independent of fasting glucose and HbA1c. J Clin Epidemiol 2004, 57(6):590-596.
32. Meigs J.B., Nathan D.M., D'Agostino R.B., Wilson P.W. Framingham Offspring study. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring study. Diabetes Care 2002, 25(10):1845-1850.